| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 261 |
| 1 | INFLIXIMAB | 242 |
| 2 | RISANKIZUMAB-RZAA | 146 |
| 3 | UPADACITINIB | 79 |
| 4 | USTEKINUMAB | 79 |
| 5 | VEDOLIZUMAB | 65 |
| 6 | PREDNISONE | 61 |
| 7 | METHOTREXATE SODIUM | 47 |
| 8 | AZATHIOPRINE | 45 |
| 9 | METHOTREXATE | 43 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROTRIPTYLINE HYDROCHLORIDE | 1 | 0.0104 |
| 1 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0062 |
| 2 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 3 | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | 1 | 0.0031 |
| 4 | OMEPRAZOLE AND SODIUM BICARBONATE | 2 | 0.0030 |
| 5 | LEVORPHANOL TARTRATE | 1 | 0.0027 |
| 6 | RISANKIZUMAB-RZAA | 146 | 0.0018 |
| 7 | ADALIMUMAB-AFZB | 4 | 0.0015 |
| 8 | ZILUCOPLAN | 1 | 0.0012 |
| 9 | BISACODYL 5MG | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 310 |
| 1 | Interleukin-23 Antagonist [EPC] | 225 |
| 2 | Corticosteroid [EPC] | 113 |
| 3 | Janus Kinase Inhibitor [EPC] | 82 |
| 4 | Interleukin-12 Antagonist [EPC] | 79 |
| 5 | Integrin Receptor Antagonist [EPC] | 76 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 7 | Purine Antimetabolite [EPC] | 46 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 43 |
| 9 | Proton Pump Inhibitor [EPC] | 37 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 225 | 0.0010 |
| 1 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 2 | Interleukin-12 Antagonist [EPC] | 79 | 0.0008 |
| 3 | Monoamine Oxidase Inhibitor [EPC] | 2 | 0.0007 |
| 4 | GLP-2 Analog [EPC] | 7 | 0.0005 |
| 5 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 6 | Janus Kinase Inhibitor [EPC] | 82 | 0.0005 |
| 7 | Purine Antimetabolite [EPC] | 46 | 0.0005 |
| 8 | Macrolide Antibacterial [EPC] | 1 | 0.0004 |
| 9 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |